Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma

Filipe V. Almeida, Stephen M. Douglass, Mitchell E. Fane, Ashani T. Weeraratna

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds